SleepCogni, an easy-to-use hand-held sleeping aid is showing remarkable results in its initial trials.
The device is designed to help insomnia sufferers break cognitive cycles that prevent sleep.
Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. If you snore loudly and feel tired even after a full night’s sleep, you might have sleep apnea.
Related Reading:
- Loona Sleepscapes app makes it to 2021 Apple Design award Finalists
- Not getting a good night’s sleep? Try these sleep gadgets and tech
- Withings and Mayo Clinic Collaborate to study obstructive Sleep Apnea via Sleep Tracking Mat
- How to use sleep tracking on your Samsung Galaxy Watch
The company is closing on its crowdfunding goal after celebrating amazing success with its clinical trial results.
The trials conducted with a cohort size of 80 people suffering from chronic insomnia at the Sheffield Hallam University showed a significant reduction of Insomnia after just seven days.
Many of those who took part reported how SleepCogni helped them control their thoughts at bedtime and fall asleep more easily with some claiming they experienced their ‘best sleep in years’ when using the device.
There was also strong feedback from trial participants that it addressed their condition better than any other remedy they’d previously tried.
The company is raising capital via a crowdfunding campaign. According to the campaign highlights, the key-value offering is as follows:
- FDA Registered as a medical device with 11 granted patents
- SleepCogni reduced Clinical Insomnia to Non-Clinical in just 7 days in trial
- £1m invested including VC Mercia, £625k in R&D grants from Innovate UK
- Medbridge Healthcare opportunity to roll out to 130 sleep clinics (subject to trial)
The successful trials follow the device’s registration with the Food and Drug Administration (FDA), announced earlier this month, opening up immediate access to an estimated 70m sleep sufferers living in the US.
According to the company, they plan on initially targeted sleep clinics in the UK and US.
The global Sleeping Aids Market was estimated at USD 64.29 Billion in 2019 and is expected to reach USD 101.7 Billion by 2026. The global Sleeping Aids Market is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2019 to 2026 according to recent research reports.
